To be a person in the year 2025 is to encounter, in one way or another, the marketing onslaught for compounded ...

Pharmaceutical giants are squaring off against telehealth companies and pharmacies selling custom-made versions of the hot ...

Hims & Hers (HIMS) went all-in on weight-loss drugs. It bet big on cheaper, compounded versions of blockbuster GLP-1 treatments like ...

Certain companies seem particularly relentless. Their ads don’t explicitly name the drugs they prescribe, but they don’t need to. Suggestive phrases like “doctor-supported weight loss” and “clinically ...

Copycat drugs can save consumers money in the short term. But the societal cost of the signals this sends to the pharmaceutical industry could be devastating. It will surely cause delays and defunding ...

While more research is needed, experts consider semaglutide a promising development in addressing alcohol addiction.

FDA ends GLP-1 drug shortage. Concerns over safety, counterfeit drugs, and high cost of brand-name versions persist; ...

Novo and Lilly’s campaigns are not limited to advertisements alone, and both companies are trying to raise awareness around obesity through research studies and conferences.

It’s hard to turn on the TV these days without seeing ads for drugs like Ozempic, Wegovy, Zepbound or Mounjaro. These ...

Iowa Attorney General Brenna Bird Friday, March 7 announced a multistate letter urging the Food and Drug Administration to take immediate action to stop the surge in dangerous, counterfeit weight ...

The versions affected are called compounded medications, which have the same active ingredients as the name brands. The ...

A new study found that fair prices for medications like Wegovy and Zepbound would be hundreds less per month than they are ...